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Summary.-Fc-receptor-bearing cells forming EA rosettes with antibody-coated
human erythrocytes (Ripley) were studied in cell suspensions and in purified prepar-
ations of mononuclear cells (MC) from 20 human malignant tumours.
The EA rosettes were studied in preparations made by cytocentrifugation and the
rosette-forming cells identified by their nonspecific-esterase activity and phagocytic
capacity.
Fc receptors were found on 16+20% of all cells in the primary cell suspensions.
Significantly more tumour-infiltrating lymphocytes had detectable Fc receptors
(33+18%) than did peripheral-blood lymphocytes in cancer patients (19+8%) and
normal control subjects (14 +6%). There was a significant correlation between the
proportion of lymphocytes lacking T and B markers (null cells) and the proportion
of lymphocytes with Fc receptors.
Fc receptors were also found on most tumour-infiltrating macrophages, on some
T lymphocytes and polymorphonuclear cells and on a smaller percentage of the
tumour cells.
The significance of the Fc receptor and its usefulness as a marker of "host infiltra-
tion" into the tumours is discussed.
HUMAN SOLID NEOPLASMS contain vari-
ous amounts ofwhite blood cells which are
believed to represent an immune response
against the malignant cells. Most authors
find the degree of mononuclear cell (MC)
infiltration in cancer positively correlated
with improved prognosis (Underwood,
1974).
We have previously examined MC
isolated from different human tumours
and demonstrated lymphocytes with T
and B markers in practically all tumours
(Svennevig et al., 1978, 1979). However, a
large proportion of the lymphocytes
lacked T and B markers, and were thus
considered as "null cells". A large propor-
tion of macrophages was also demon-
strated in the tumours (Svennevig &
Svaar, 1979).
In peripheral blood, a third population
of lymphocytes lacking markers for both
T and B lymphocytes has been shown to
carry receptors for the Fc portion of IgG
(Fr0land & Natvig, 1973). The present
study was carried out in order to examine
the presence of the Fc receptor on MC
harvested from 20 human neoplasms, and
whether the Fc marker may be used to
measure "host infiltration" (Kerbel &
Pross, 1976) into the tumours.
MATERIALS AND METHODS
Patients and specimens.-Fresh biopsy
specimens weighing 0 5-6 0 g, were taken as
a representative sample from 20 tumours
removed by operation. No blood transfusions
or irradiation had been given previously. All
visible fat and connective tissue was cut away
and the biopsy specimens were washed
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thoroughly to remove contaminating white
blood cells.
Tumour-cell suspensions-.The tumour tis-
sue was disaggregated mechanically by cut-
ting small pieces into phosphate-buffered
saline (PBS) and squeezing them through
fine metal meshes followed by magnetic
stirring of the suspension for 30 min. Non-
disaggregated tissue fragments were removed
by filtering the cell suspension through
double-layered gauze.
The degree of contaminating peripheral-
blood cells was calculated from the lympho-
cyte/erythrocyte ratio in both tumour-cell
suspension and peripheral blood (Svennevig
et al., 1978) and viability was assessed by
trypan-blue exclusion.
Isolation and characterization of MC.-The
tumour-cell suspensions were layered on
Lymphoprep (Nyegaard & Co. Oslo, Norway)
and centrifugated at 400 g for 40 min at room
temperature. The MC were harvested from
the interface, washed twice with PBS, and
examined for ability to form E rosettes with
untreated sheep red blood cells (SRBC) as a
marker for T lymphocytes, for the presence of
surface-bound Ig as a marker of B lympho-
cytes, for ability to ingest latex particles and
to form EA rosettes with human 0R1R2
erythrocytes coated with anti-CD Ripley.
Removal of adherent cells.-Tn 10 cases the
MC were resuspended in medium RPMI 1640
supplemented with 20% foetal calfserum and
incubated overnight in Falcon culture dishes
to remove adherent cells. Both the monocyte/
macrophage-depleted lymphocyte fraction
and the adherent cells were then examined
for cell markers as described above.
Cytocentrifugepreparations-.Fixed prepar-
ations were made from all suspensions by
cytocentrifugation (Cytospin, Shandon-
Elliott) at 600 rev/min. The E- and EA-
rosetting cells were stained with May-
Grunwald-Giemsa and with a-naphthyl ace-
tate, and examined for non-specific-esterase
activity and phagocytic capacity. Technical
details concerning the use of cell markers and
esterase techniques have been given in an
earlier report (Andersson & Svennevig, 1981).
Monocytes and macrophages are stained
diffusely red by these techniques whereas
distinct dots or a scattered cytoplasm reaction
is seen in T lymphocytes.
Tumour cells-.Malignant cells from all 20
tumours were recovered from the bottom of
the centrifuge tubes following the isolation of
MC, and then washed and examined for
EA-rosetting cells, which were further charac-
terized in cytocentrifuge preparations.
Peripheral-blood cells.-MC were isolated
from peripheral blood from all 20 cancer
patients and from 20 healthy controls and
examined for T and B markers, phagocytosis
and ability to form EA rosettes with anti-CD
Ripley-coated human erythrocytes. In 10
patients and 10 control subjects, lymphocytes
and monocytes were further separated by
adherence to plastic.
Statistics.-All data are given as mean +
s.d. and the t-test was used for calculation of
probabilities.
RESULTS
Isolation of MC from tumour tissue
Twenty tumours were examined. Two
cell suspensions were excluded because of
contamination by PBL; it was calculated
that 5-10% ofthe lymphocytes could have
come from peripheral blood. The sus-
pensions from the remaining 18 tumours
contained 3( ± )3% lymphocytes, 1 + 1%
plasma cells, 6 + 6% macrophages and
6 + 50 polymorphonuclear cells (PMN)
(Table I). From the erythrocyte/lympho-
cyte ratio it was calculated that less than
10% of the lymphocytes in these suspen-
sions came from peripheral blood.
A sufficient number of MC (0.3-7.8 x
106/g tumour tissue) to allow the use of
cell markers could be isolated from 15 out
of 18 tumour-cell suspensions. The purified
preparations contained 66 + 22% MC. Re-
covery was 57 + 29% for lymphocytes and
24 + 3400 for macrophages, when the
initial number of cells in the primary cell
suspensions was considered. More than
9000 of the MC excluded trypan blue,
while 60 + 29% of the tumour cells were
viable. After removal ofadherent cells, the
lymphocyte-enriched fraction consisted of
70 + 18% lymphocytes, while 79 + 16% of
all adherent cells had the properties of
macrophages; i.e. they were phagocytic
and exhibited a diffuse esterase activity.
Cell markers
Fc-receptor-bearing cells were found in
the primary cell suspensions from all
202Fe RECEPTORS IN HUMAN TUMOURS
TABLE I.-Relative content of tumour infiltrating lymphocytes (TIL), macrophages (TIM)
and polymorphonuclear cells (PMN) in cell suspensions from 20 human neoplasms
(mean and range)
No. of cases %/ TIL % TIM % PMN
5 Carcinoma of the colon 3 (2-6) 3 (1-5) 4 (3-5)
4 Carcinoma of the stomach 2 (0.5-5) 4 (3-7) 5 (0-10)
6 Carcinoma of the lung* 4 (1-12) 13 (3-19) 8 (0-22)
1 Sarcoma of the thoracic wall 0 2 6
1 Carcinoma of the breast*
3 Carcinoma of the rectum 3 (1-5) 2 (0.5-4) 6 (2-12)
Mean+s.d. 3+3 6+6 6+5
* Data not given in 2 cases due to contamination by PBL.
TABLE II.-Subpopulations of lymphocytes in tumour tissue and peripheral blood (mean
and range)
No. of cases % E % sIg % null % EA
15 TIL 49 (6-80) 13 (4-30) 38 (12-85) 33 (10-69)
20 PBL, cancer patients 67 (40-85) 11 (6-18) 22 (5-50) 19 (7-35)
20 PBL, normal controls 73 (54-86) 12 (6-18) 15 (1-34) 14 (5-24)
tumours; 16+ 20% of all nucleated cells
formed EA rosettes.
Of the isolated tumour-infiltrating lym-
phocytes (TIL), 49 + 20% formed spon-
taneous rosettes with SRBC, and 13 + 6%
had membrane-bound Ig, while 38 + 22%
lacked T and B markers (null cells). The
relative proportion of null lymphocytes
was significantly higher than for PBL in
cancer patients and normal controls (P=
0 01) (Table II).
A significantly higher percentage of
TIL (33 + 18%) had detectable Fc re-
ceptors (Fig. 1) than did the PBL in
cancer patients (19+8%) and normal
controls (14 + 6%), and there was a good
correlation between the relative number
ofnull cells in the tumours and the number
of lymphocytes with Fc receptors (P=
0-01) (Table III). Comparable data were
obtained whether cytocentrifuge prepara-
tions from MC suspensions or monocytes-
depleted lymphocyte suspensions were
used. Of the EA-rosetting TIL, 15+ 7%
had esterase-positive dots characteristic of
T lymphocytes, which did not differ
significantly from the results for PBL in
the patients (11+5%) and normal con-
trols (10 + 6%).
There was no significant difference in
TABLE III.-Cell markers on lymphocytes isolatedfrom 15 tumour-cell suspensions
Bronchial carcinoma
Carcinoma of the stomach
Carcinoma of the colon
Carcinoma of the rectum
Mean
%E
22
43
50
50
54
57
60
64
80
17
46
75
6
56
50
49
% sIg
12
14
9
16
14
20
13
8
8
4
30
12
9
16
8
13
% null
66
43
41
34
32
23
27
28
12
79
24
13
85
28
42
38
% EA
60
42
40
12
38
32
25
18
10
69
35
14
56
33
17
33
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FIG. 3.-Neutrophilic granulocyte forming an EA rosette. Technique as Fig. 2.
FIG. 4.-Esterase-negative, non-phagocytic tumour cells from a colon carcinoma, binding anti-CD
Ripley-coated human erythrocytes to their surface. Technique as Fig. 2.
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Fe receptors on peripheral-blood mono-
cytes from cancer patients (82 + 120%) and
normal controls (74 + 14%), and a similar
percentage of tumour-infiltrating mac-
rophages formed EA rosettes (82 + 13%)
(Fig. 2).
Both neutrophilic and eosinophilic
granulocytes were capable of forming EA
rosettes, regardless of whether they were
isolated from peripheral blood (36 + 28%)
or cancer tissue (36 + 170%) (Fig. 3).
A small percentage (9 + 150%) of ester-
ase-negative, non-phagocytic cells morph-
ologically similar to malignant tumour
cells from 19/20 tumours formed typical
EA rosettes (Fig. 4). However, EA
rosettes formed by tumour cells were less
stable and often difficult to fixate by
cytocentrifugation.
DISCUSSION
Fc receptors have previously been
demonstrated in both human (T0nder &
Thunold, 1973; T0nder et al., 1974; Wood
& Gollahon, 1977; Wesenberg, 1978) and
experimental tumours (Kerbel & Pross,
1976; Haskill, 1977; Thomson et al.,
1979). However, there have been con-
flicting results on the identity of the
receptor-bearing cells. Some previous re-
ports have established that most Fe
receptor-bearing cells within tumours were
macrophages (Kerbel & Pross, 1976, Wood
& Gollahon, 1977) and the Fe receptor has
thus been caused as an index of host
infiltration into the tumours (Kerbel &
Pross, 1976). Other authors have claimed
the presence of Fe receptors on tumour
cells also (T0nder et al., 1978; Biran et al.,
1979) and on a large proportion of TIL
(Hayry & T0tterman, 1978; Vose et al.,
1977). In malignant melanoma, the largest
population of infiltrating cells were ester-
ase-negative, non-phagocytic, non-T and
non-B cells with Fc receptors (Roubin et
al., 1975).
In the present study, MC were isolated
from tumour-cell suspensions by the
widely used method of gradient separa-
tion, initially described by B0yum (1968).
Although many macrophages were lost, a
high degree of purity and cell yield could
be obtained for tumour lymphocytes,
probably due to the use of fresh biopsy
material, simple and fast procedures, a
high degree of dilution of all cell sus-
pensions and by reducing all washing
procedures to a minimum. Unsuccessful
separation due to cell aggregation (Sven-
nevig et al., 1978) could be prevented by
removing non-disaggregated material and
cell debris from the primary cell sus-
pensions before the isolation procedure.
By comparing cell suspensions with tissue
sections from human tumours, we have
previously demonstrated a correlation in
respect of the inflammatory cells, indicat-
ing that tumour-cell suspensions, despite
cell loss and cell damage, may reflect the
real situation within the tumours (Sven-
nevig & Holter, 1981).
Human OR1R2 erythrocytes coated
with anti-CD Ripley have been shown to
react with Fc receptors on null lympho-
cytes, some T lymphocytes, monocytes
and PMN, while Fe receptors on B cells
were not detected by this assay (Shaw et
al., 1979, Andersson & Svennevig, 1981).
In the present study the superimposition
of several markers in cytopreparations
(Ranki et al., 1976) demonstrated Fe
receptors on at least 4 cell types: lympho-
cytes, macrophages, PMN and tumour
cells. The study also demonstrated that
the problem of enumerating rosettes in
preparations containing more than 1 cell
type can be overcome by identifying the
rosetting cells in preparations fixed after
cytocentrifugation. This is only possible
when working with strong and stable
rosettes. Cytocentrifuge fixation ofrosettes
using other types ofindicator cells, such as
antibody-coated chicken or sheep erythro-
cytes, has been less successful in our
hands.
By correlating the percentages of each
cell type carrying Fe receptors with the
relative content of the cell populations in
the primary cell suspensions, it may be
calculated that only 50°/0 of the EA
rosettes were formed by white blood cells,
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while 50% were formed by tumour cells.
Thus the Fc receptor should not be used as
the sole marker for host infiltration into
solid human tumours.
Lymphocytes lacking T and B markers
represent only a small proportion in
normal control subjects. However, in
many conditions, such as progressing
cancer, an increased proportion of null
lymphocytes is found. This population
may even dominate in the lymphocyte
response at the tumour site (Hayry &
T0tterman, 1978; Svennevig et al., 1978;
Svennevig & Holter, 1981). The present
study demonstrated a good correlation
between the percentage of null lympho-
cytes and Fc-receptor-bearing lympho-
cytes in the tumours. The results confirm
our previous findings of low percentages
ofT lymphocytes in some tumours, though
the proportion in peripheral blood was
within the normal range (Svennevig &
Holter, 1981). The present study extends
previous findings by demonstrating that
most non-T lymphocytes carry receptors
for the Fc portion of IgG.
The demonstration of an increased
portion of Fc-receptor-bearing cells may
reflect a real increase in the number of
null cells, immature T cells (Balch et al.,
1980; Chiao et al., 1980) or T suppressor
cells (Ferranini et al., 1980). Although
Fc-receptor-bearing lymphocytes from
peripheral blood may act as effector cells
in antibody-dependent cytotoxicity (Dob-
loug et al., 1980), no cytotoxic activity has
been demonstrated for TIL (Vose et al.,
1977), and recent investigations have also
failed to demonstrate any NK-cell effect
(Moore & Vose, 1981). It is interesting,
however, that an increased suppressor-cell
activity has been demonstrated in human
tumours (Vose & Moore, 1979). Non-
specific Ig may also bind to Fc receptors
of both target and effector cells (Mac-
Sween & Eastwood, 1980) and thereby
hinder the immune reaction at the tumour
site.
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